glp 1 dry eyes As the use of GLP-1 medications continues to rise, researchers are exploring their potential impact on eye health. While these drugs can help manage diabetes and promote weight loss, recent studies suggest glp-1 receptor agonist dry eye

Viewing tirzepatide before and after results alongside expected semaglutide outcomes helps calibrate expectations realistically

The original Western blots are included as Source Data File

Some of these proteins are also released by immune cells that are recruited to adipose tissue and participate in a feed forward loop for inflammation [19]

Exclusivity Periods Some GLP-1 drugs are still in the exclusivity period, while others can be challenged: Liraglutide : Approved in 2010 (Victoza) and 2014 (Saxenda), its exclusivity expired in 2017, and the first generic was approved by the FDA in December 2024

Developed by Metabolic Pharmaceuticals as a candidate anti-obesity agent